Skip to main content
. 2023 Jan 5;13:1084960. doi: 10.3389/fimmu.2022.1084960

Table 3.

Incidence rate ratio (IRR) of bullous pemphigoid (BP) with the prescription of DPP4 inhibitors based on MarketScan data.

DPP4 inhibitors BP cases Incidence rate (% per person-year) IRR (95% CI) Z score –log10 p
+ 179/112,549 0.148 1.68 (1.45–1.95) 6.93 11.4
40,874/31,336,175 0.088